Free Trial
→ Arizona-made nanochips the new millionaire maker? (From Banyan Hill Publishing) (Ad)tc pixel

Eurofins Scient (OTCMKTS:ERFSF) Sees Strong Trading Volume - Still a Buy?

Written by MarketBeat
October 21, 2025
Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scientific (OTCMKTS:ERFSF) experienced a significant increase in trading volume, with approximately 3,850 shares traded, marking a 164% rise from the previous session.
  • The stock is currently rated "Hold" by analysts, with Citigroup maintaining a "neutral" stance and only one analyst giving it a "Strong Buy" rating.
  • As of the latest trading session, Eurofins' stock price dropped by 6.0%, closing at $69.42, down from the previous close of $74.53.
  • Interested in EUROFINS SCIENT? Here are five stocks we like better.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 3,850 shares traded hands during trading, an increase of 164% from the previous session's volume of 1,460 shares.The stock last traded at $69.42 and had previously closed at $74.53.

Analyst Ratings Changes

Separately, Citigroup reiterated a "neutral" rating on shares of Eurofins Scient in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold".

View Our Latest Analysis on ERFSF

Eurofins Scient Trading Down 6.0%

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The company has a fifty day moving average price of $75.22 and a 200-day moving average price of $69.88.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUROFINS SCIENT Right Now?

Before you consider EUROFINS SCIENT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.

While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.